These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25619110)

  • 41. Are overdoses treated by ambulance services an opportunity for additional interventions? A prospective cohort study.
    Gjersing L; Bretteville-Jensen AL
    Addiction; 2015 Nov; 110(11):1767-74. PubMed ID: 26118947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS).
    Havard A; Teesson M; Darke S; Ross J
    J Subst Abuse Treat; 2006 Jun; 30(4):355-62. PubMed ID: 16716851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can we predict retention in longitudinal studies of substance use? Findings from the Australian Treatment Outcome Study.
    Marel C; Mills K; Darke S; Ross J; Burns L; Teesson M
    Addict Behav; 2015 Dec; 51():38-43. PubMed ID: 26210911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia.
    Darke S; Sunjic S; Zador D; Prolov T
    Drug Alcohol Depend; 1997 Jul; 47(1):45-53. PubMed ID: 9279497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Years of potential life lost amongst heroin users in the Australian Treatment Outcome Study cohort, 2001-2015.
    Darke S; Marel C; Mills KL; Ross J; Slade T; Tessson M
    Drug Alcohol Depend; 2016 May; 162():206-10. PubMed ID: 27021806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence.
    Mills KL; Teesson M; Ross J; Darke S
    Addiction; 2007 Mar; 102(3):447-54. PubMed ID: 17298653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study.
    Evans JL; Tsui JI; Hahn JA; Davidson PJ; Lum PJ; Page K
    Am J Epidemiol; 2012 Feb; 175(4):302-8. PubMed ID: 22227793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns and correlates of attempted suicide amongst heroin users: 11-year follow-up of the Australian treatment outcome study cohort.
    Darke S; Ross J; Marel C; Mills KL; Slade T; Burns L; Teesson M
    Psychiatry Res; 2015 Jun; 227(2-3):166-70. PubMed ID: 25908265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
    Ngo HT; Tait RJ; Hulse GK
    J Psychopharmacol; 2011 Jun; 25(6):774-82. PubMed ID: 20360157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence.
    Darke S; Hetherington K; Ross J; Lynskey M; Teesson M
    Drug Alcohol Rev; 2004 Jun; 23(2):177-83. PubMed ID: 15370024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective observational study of heroin users in Johannesburg, South Africa: Assessing psychiatric comorbidities and treatment outcomes.
    Morgan N; Daniels W; Subramaney U
    Compr Psychiatry; 2019 Nov; 95():152137. PubMed ID: 31669789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morbidity associated with non-fatal heroin overdose.
    Warner-Smith M; Darke S; Day C
    Addiction; 2002 Aug; 97(8):963-7. PubMed ID: 12144598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reductions in criminal convictions after addiction treatment: 5-year follow-up.
    Gossop M; Trakada K; Stewart D; Witton J
    Drug Alcohol Depend; 2005 Sep; 79(3):295-302. PubMed ID: 16102373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychiatric comorbidity in young heroin users.
    Rodríguez-Llera MC; Domingo-Salvany A; Brugal MT; Silva TC; Sánchez-Niubó A; Torrens M;
    Drug Alcohol Depend; 2006 Sep; 84(1):48-55. PubMed ID: 16388919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "It's Russian roulette": adulteration, adverse effects and drug use transitions during the 2010/2011 United Kingdom heroin shortage.
    Harris M; Forseth K; Rhodes T
    Int J Drug Policy; 2015 Jan; 26(1):51-8. PubMed ID: 25444768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns and Correlates of Sustained Heroin Abstinence: Findings From the 11-Year Follow-Up of the Australian Treatment Outcome Study.
    Darke S; Marel C; Slade T; Ross J; Mills KL; Teesson M
    J Stud Alcohol Drugs; 2015 Nov; 76(6):909-15. PubMed ID: 26562598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-fatal opioid overdose and major depression among street-recruited young heroin users.
    Chahua M; Sordo L; Barrio G; Domingo-Salvany A; Brugal MT; Molist G; de la Fuente L; Bravo MJ;
    Eur Addict Res; 2014; 20(1):1-7. PubMed ID: 23921233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overdose among heroin users in Sydney, Australia: II. responses to overdose.
    Darke S; Ross J; Hall W
    Addiction; 1996 Mar; 91(3):413-7. PubMed ID: 8867203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.
    Teesson M; Havard A; Fairbairn S; Ross J; Lynskey M; Darke S
    Drug Alcohol Depend; 2005 Jun; 78(3):309-15. PubMed ID: 15893162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.